Analytical Data
-
基因名
PPHLN1
- Application
-
别名
Gastric cancer antigen Ga50
-
种属
Mouse
-
表达系统
E. coli
-
标签
N-His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q8K2H1
-
表达区间
Met1~Phe312
-
分子量
48kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
PPHLN1, or Phosphoethanolamine Phosphatase-like Protein 1, is a protein that has garnered interest in the field of molecular biology and biochemistry due to its potential roles in cellular processes and disease mechanisms. Initial studies suggest that PPHLN1 may be involved in the regulation of lipid metabolism and signal transduction pathways, which are crucial in various physiological and pathological contexts. Its reconstitution into recombinant forms has enabled researchers to investigate its enzymatic properties and interactions with other cellular components, shedding light on its functional significance. Understanding the structure and function of PPHLN1 can provide valuable insights into its role in health and disease, particularly in the contexts of metabolic disorders and cancer. Furthermore, the recombinant protein can serve as a valuable tool for high-throughput screening in pharmaceutical applications, as well as a potential biomarker for specific diseases. Current research is focused on elucidating the precise mechanisms by which PPHLN1 modulates cellular functions and exploring its therapeutic potential. This ongoing investigation highlights the importance of characterizing recombinant proteins like PPHLN1 in advancing our knowledge of complex biological systems and developing novel therapeutic strategies.
